Description

Cagrilintide 5 mg

Cagrilintide is a synthetic, long-acting amylin analogue investigated experimentally in relation to amylin receptor signalling and associated metabolic and endocrine regulatory pathways.

Cagrilintide is studied in biochemical and pharmacological research involving peptide-receptor interactions, calcitonin receptor-associated signalling and the wider family of amylin-related endocrine mechanisms.

Benchmark Peptides supplies Cagrilintide as a research material for laboratory and analytical use only. This product is not supplied or intended for human or veterinary use.

Product Specifications

• Product: Cagrilintide
• Compound Classification: Synthetic amylin analogue
• Catalogue Reference: CGI5
• Quantity: 5 mg
• Physical Form: Lyophilised material
• Appearance: White to off-white
• Grade: Research grade
• Batch: See current batch information
• Analytical Documentation: See current Certificate of Analysis, where available

Research Information

Cagrilintide is a synthetic peptide analogue investigated in relation to amylin receptor activity and associated endocrine and metabolic signalling mechanisms.

Amylin is a naturally occurring peptide hormone associated with pancreatic endocrine physiology. Amylin receptor complexes are formed through interactions between the calcitonin receptor (CTR) and receptor activity-modifying proteins (RAMPs).

These receptor complexes form part of a wider family of signalling systems investigated in metabolic and neuroendocrine research.

Scientific research involving Cagrilintide and its associated pathways includes investigation of:

• Amylin receptor signalling
• Calcitonin receptor (CTR) interactions
• Receptor activity-modifying proteins (RAMPs)
• Peptide-receptor binding mechanisms
• Amylin-associated endocrine pathways
• Pancreatic peptide signalling
• Metabolic regulatory mechanisms
• Neuroendocrine signalling pathways
• Receptor-mediated intracellular signalling
• Amylin receptor pharmacology

Experimental research involving Cagrilintide includes investigations of receptor interactions, downstream cellular signalling and the molecular characteristics of amylin-associated regulatory pathways.

The available scientific literature includes laboratory, preclinical and clinical investigations. Findings from these studies should not be interpreted as establishing suitability of the supplied research material for any particular application.

Information provided by Benchmark Peptides is intended solely to identify and characterise the research material supplied. It should not be interpreted as medical information, treatment guidance or a recommendation for use.

Batch & Quality Information

Batch-specific analytical information is provided through the Certificate of Analysis where available for this product.

Where available, the Certificate of Analysis provides information including:

• Batch identification
• Analytical identity
• Analytical purity
• Testing methodology
• Laboratory information
• Test date and associated analytical data

Analytical results relate specifically to the identified batch and should not be interpreted as establishing suitability for any particular application.

Storage & Laboratory Handling

Store the sealed research material according to the conditions specified in the applicable product or batch documentation.

For longer-term laboratory storage, protect the material from excessive heat, moisture and direct light, subject to the manufacturer’s documented storage requirements.

Where the material is prepared in solution for legitimate analytical or laboratory work, appropriate preparation, handling and storage conditions should be determined by the researcher’s validated laboratory protocol.

Package Contents

• 1 × Cagrilintide research vial
• 5 mg nominal peptide content
• Sealed closure
• Batch identification

Product Category

Metabolic Research

This material is categorised according to its relevance to experimental research involving amylin receptor activity, peptide-receptor interactions and associated metabolic and endocrine signalling pathways.

Important Notice

FOR RESEARCH USE ONLY

Supplied exclusively as a laboratory research material.

NOT FOR HUMAN OR VETERINARY USE.

Not supplied for administration, diagnosis, treatment, cure or prevention of any disease.

Researchers are responsible for ensuring that acquisition, possession, handling and use comply with all applicable laws, regulations and institutional requirements.